[go: up one dir, main page]

NO20090233L - Ny sammensetning som har affinitet for amyloid - Google Patents

Ny sammensetning som har affinitet for amyloid

Info

Publication number
NO20090233L
NO20090233L NO20090233A NO20090233A NO20090233L NO 20090233 L NO20090233 L NO 20090233L NO 20090233 A NO20090233 A NO 20090233A NO 20090233 A NO20090233 A NO 20090233A NO 20090233 L NO20090233 L NO 20090233L
Authority
NO
Norway
Prior art keywords
amyloid
affinity
salt
carbon atoms
substituent
Prior art date
Application number
NO20090233A
Other languages
English (en)
Inventor
Akio Hayashi
Anthony Eamon Storey
Denis Raymond Christophe Bouvet
Daisaku Nakamura
Shigeyuki Tanifuji
Shinya Takasaki
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20090233L publication Critical patent/NO20090233L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives en forbindelse som har affinitet mot amyloid, som viser tilstrekkelig hurtig klaring fra normal vev, og som har lav toksisitet som mutagenisitet, og som har den generelle formel (1): eller et salt derav, der R1 er en gruppe valgt fra hydrogen, hydroksyl, karboksyl, sulfat, amino, nitro, cyano, en alkylsubstituent med ett til 4 karbonatomer eller en alkoksysubstituent med ett til 4 karbonatomer; R2 er en radioaktiv halogensubstituent; og m er et helt tall 0 til 2, og et lav-toksisk diagnostisk middel for Alzheimers sykdom omfattende en forbindelse representert ved formelen ovenfor eller et salt derav.
NO20090233A 2006-06-21 2009-01-14 Ny sammensetning som har affinitet for amyloid NO20090233L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80535606P 2006-06-21 2006-06-21
JP2006188034 2006-07-07
PCT/JP2007/062503 WO2007148755A1 (ja) 2006-06-21 2007-06-21 新規アミロイド親和性化合物

Publications (1)

Publication Number Publication Date
NO20090233L true NO20090233L (no) 2009-02-11

Family

ID=38833493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090233A NO20090233L (no) 2006-06-21 2009-01-14 Ny sammensetning som har affinitet for amyloid

Country Status (9)

Country Link
US (1) US8277777B2 (no)
EP (1) EP2042501B1 (no)
KR (1) KR20090025282A (no)
CN (1) CN101501033B (no)
AU (1) AU2007261985B2 (no)
CA (1) CA2655826A1 (no)
IL (1) IL196046A0 (no)
NO (1) NO20090233L (no)
WO (1) WO2007148755A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200803903A (en) 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
ES2376491T3 (es) 2006-05-19 2012-03-14 Nihon Medi-Physics Co., Ltd. Compuesto que tiene afinidad por amiloide.
CA2670436A1 (en) 2006-11-30 2008-06-05 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2213672A4 (en) * 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
JP5313158B2 (ja) * 2007-10-26 2013-10-09 日本メジフィジックス株式会社 新規アミロイド親和性化合物
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
IN2014DN00185A (no) * 2011-06-24 2015-07-10 Nihon Mediphysics Co Ltd
DK2991983T3 (en) 2013-04-29 2017-05-08 Hoffmann La Roche 2-PHENYL OR 2-HETARYLIMIDAZOLE [1,2-a] PYRIDINE DERIVATIVES
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用
DK3197277T3 (da) * 2014-08-29 2022-01-31 Chdi Foundation Inc Prober til billeddannelse af huntingtin-protein
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
CN108822105A (zh) * 2018-08-14 2018-11-16 河南师范大学 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791117A (en) 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
US4833149A (en) 1986-09-22 1989-05-23 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines
US4727145A (en) * 1986-09-22 1988-02-23 Ortho Pharmaceutical Corporation 2- Or 3- aryl substituted imidazo [1,2-a]pyridines
NZ322674A (en) 1995-10-17 1999-08-30 Searle & Co Method of detecting cyclooxygenase-2
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
CA2340394A1 (en) 1998-08-20 2000-03-02 Jorge R. Barrio Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles
JP4025468B2 (ja) 1999-07-29 2007-12-19 三井化学株式会社 有機電界発光素子
WO2001074813A2 (en) * 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
US20010051632A1 (en) 2000-03-31 2001-12-13 Wenying Chai Phenyl-substituted indolizines and tetrahydroindolizines
US6908929B2 (en) 2000-03-31 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
US6514969B2 (en) 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
DE10040016A1 (de) 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
HU230581B1 (hu) 2000-08-24 2017-01-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
HUP0304083A2 (hu) 2001-02-26 2004-03-29 Bristol-Myers Squibb Pharma Company Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
DE60217090T2 (de) 2001-04-23 2007-07-12 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
KR100947913B1 (ko) 2001-08-27 2010-03-17 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 스틸벤 유도체 및 이것을 아밀로이드 플라크의 결합 및영상화에 사용하는 용도
GB0205281D0 (en) 2002-03-06 2002-04-17 Novartis Ag Organic compounds
EP1356827A1 (en) 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
AU2003242233A1 (en) 2002-06-12 2003-12-31 Bf Research Institute, Inc. Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation
BR0215913A (pt) 2002-11-05 2005-08-09 Ion Beam Applic Sa Composição de radiofármacos rotulados com 18-f e processo para obtê-los
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
BRPI0418328A (pt) 2003-12-31 2007-05-02 Schering Plough Ltd controle de parasitas em animais pelo uso de derivados de imidazo [1,2-b]piridazina
WO2007002540A2 (en) * 2005-06-24 2007-01-04 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
US20080219922A1 (en) * 2005-09-12 2008-09-11 Goodman Mark M Alzheimer's Disease Imaging Agents
ES2376491T3 (es) 2006-05-19 2012-03-14 Nihon Medi-Physics Co., Ltd. Compuesto que tiene afinidad por amiloide.
EP2213672A4 (en) 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
JP5313158B2 (ja) 2007-10-26 2013-10-09 日本メジフィジックス株式会社 新規アミロイド親和性化合物
TW200922629A (en) 2007-10-30 2009-06-01 Nihon Mediphysics Co Ltd Utilization of novel compounds with amyloid affinity and method of producing the same

Also Published As

Publication number Publication date
WO2007148755A1 (ja) 2007-12-27
IL196046A0 (en) 2009-09-01
KR20090025282A (ko) 2009-03-10
AU2007261985A1 (en) 2007-12-27
AU2007261985B2 (en) 2012-04-19
US20100092387A1 (en) 2010-04-15
HK1133254A1 (en) 2010-03-19
CA2655826A1 (en) 2007-12-27
EP2042501A1 (en) 2009-04-01
EP2042501B1 (en) 2017-04-12
CN101501033B (zh) 2012-08-01
CN101501033A (zh) 2009-08-05
EP2042501A4 (en) 2012-11-21
US8277777B2 (en) 2012-10-02

Similar Documents

Publication Publication Date Title
NO20090233L (no) Ny sammensetning som har affinitet for amyloid
NO20085265L (no) Nye forbindelser som har affinitet for amyloid
WO2009054497A1 (ja) 新規アミロイド親和性化合物
EA201070323A1 (ru) Замещенное производное пиразола
NO20084897L (no) Ny forbindelse med affinitet til amuloid
NO20074718L (no) BCRP/ABCG2 inhibitor
MY153045A (en) Oxopyrazine derivative and herbicide
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
WO2009054496A1 (ja) 新規アミロイド親和性化合物
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
ATE515505T1 (de) Heterocyclische fxr-bindende verbindungen
NO20076524L (no) Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme
MY142807A (en) Benzimidazole derivative and use thereof.
NO20073720L (no) Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer
MY158052A (en) Indole compound
HRP20130653T1 (en) Pyrrole compounds
IL198995A0 (en) Novel compound having affinity for amyloid
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
NO20082747L (no) Arylisoksazol-4-yl-imidazolderivater
WO2008014955A3 (en) Fungicidal compounds and compositions
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
MX2010001566A (es) Derivado de aminopirazolamida.
BRPI0606845A2 (pt) derivados de (1,5-difenil-1h-pirazol-3-il)oxadiazol, o respectivo preparo e a respectiva aplicação em terapêutica
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application